Kepler Vision Technologies, a spin-off company from the University of Amsterdam, secured a significant €1.5M investment from ROM InWest last month. The company will use the funds to accelerate the production of its ‘Kepler Night Nurse’ solution, a smart technology for care home fall detection. The company is now positioned for global expansion, targeting the UK and US markets.
Kepler Vision Technology develops an AI that looks after the well-being of humans, particularly in eldercare centres. The company has been securing the funds to accelerate the production of its ‘Kepler Night Nurse’ solution which is a computer vision-based detection system designed to monitor patients’ body position and posture. By utilising machine learning training and computer vision, the technology can detect falls, patient discomfort, and abnormal behaviour and immediately notify the nursing staff. This reduces the workload of healthcare professionals.
Kepler Vision Technology is being led by CEO Harro Stokman, former UvA researcher in Computer Vision. It was founded in 2018 with intellectual property generated by Cees Snoek and Arnold Smeulders. Kepler got a kickstart with an initial investment from UvA Venture. The initial setup was to explore computer vision cases. Later on, the idea came to focus on care home fall detection.
Harro Stokman, CEO of Kepler Vision Technologies, says,
“The healthcare industry has been struggling with acute staff shortages for years. This problem is only exacerbated by the aging population. A quarter of the current workforce will retire in the next five years while the number of elderly people continues to grow. Elder care, therefore, needs more support than ever. Thanks to ROM InWest’s investment, we can scale up our Kepler Night Nurse production to help more healthcare professionals in their work. My goal is for our software to be accessible around the world, and with great support like this, we are getting closer to that goal.”
Quote is from: siliconcanals.com by Vignesh R. – April 11, 2024
VU-AMS is on a mission to revolutionize how we understand and manage stress-related health issues. Now an official VU spin-off, there are big plans for clinical applications. Founder of VU AMS Martin Gevonden explains: “We offer researchers autonomic biomarkers that are valid, reliable and easy to use, without getting under the skin.” After thriving in […]
NewsAmsterdam researchers have secured Biotech Booster funding for a total of six projects, that include a promising cancer treatment, a new diagnostic method for Alzheimer’s Disease, an implant helping blindness, lab innovation in biotechnology, and a nutritional intervention for mental health. The researchers will develop a solid business case for their innovations in the time […]
NewsPULSE Sport, a start-up from the Demonstrator Lab, has reached a significant milestone by winning the prestigious 14th Dutch Sports Innovation Award. The company’s flagship product, a cutting-edge athlete management system, integrates advanced software and artificial intelligence to revolutionize athlete health and performance monitoring. About the Innovation PULSE Sport’s athlete management system provides a holistic […]
News